Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02169752
What this trial is testing

Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension

Who this might be right for
Pre-Pulmonary Atrial Hypertension
National Jewish Health 7
Testing effectiveness (Phase 2)Looking for participantsNCT05587712
What this trial is testing

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 42
Large-scale testing (Phase 3)Looking for participantsNCT07218029
What this trial is testing

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 815
Large-scale testing (Phase 3)Ended earlyNCT00310830
What this trial is testing

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Actelion 14
Early research (Phase 1)Study completedNCT02746237
What this trial is testing

Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585

Who this might be right for
Pulmonary Arterial Hypertension
Karos Pharmaceuticals 120
Not applicableStudy completedNCT03304548
What this trial is testing

Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 10
Large-scale testing (Phase 3)Study completedNCT00091715
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II

Who this might be right for
Pulmonary Hypertension
Actelion 185
Early research (Phase 1)Study completedNCT05185011
What this trial is testing

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

Who this might be right for
Erectile DysfunctionPulmonary Arterial Hypertension
Vigonvita Life Sciences 24
Very early researchWithdrawnNCT01950585
What this trial is testing

Hydroxyurea in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Not Yet RecruitingNCT05660863
What this trial is testing

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets

Who this might be right for
Pulmonary Arterial Hypertension
Guangzhou Magpie Pharmaceuticals Co., Ltd. 16
Not applicableLooking for participantsNCT02691689
What this trial is testing

Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions

Who this might be right for
Heart Defects, CongenitalPulmonary Arterial HypertensionGenetic Testing
Universitaire Ziekenhuizen KU Leuven 21
Not applicableStudy completedNCT01355380
What this trial is testing

Efficacy of Ventavis Used in Real-life Setting.

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 55
Large-scale testing (Phase 3)WithdrawnNCT01557660
What this trial is testing

Inhaled Treprostinil for PAH: Open-label Extension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics
Early research (Phase 1)Active Not RecruitingNCT07751120
What this trial is testing

Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in PAH.

Who this might be right for
Pulmonary Arterial Hypertension
University of Minnesota 24
Testing effectiveness (Phase 2)Looking for participantsNCT01712620
What this trial is testing

Spironolactone for Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
National Institutes of Health Clinical Center (CC) 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04273945
What this trial is testing

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 935
Testing effectiveness (Phase 2)Study completedNCT00105209
What this trial is testing

Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Kawut, Steven, MD 20
Not applicableStudy completedNCT00909467
What this trial is testing

Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases

Who this might be right for
Myeloproliferative DisorderMyelodysplastic SyndromesPulmonary Hypertension
Medical University of Graz 86
Large-scale testing (Phase 3)Study completedNCT04576988
What this trial is testing

Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 324
Large-scale testing (Phase 3)Study completedNCT00709956
What this trial is testing

Iloprost Power 15 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 64
Next Page